Tandem Diabetes Care, Inc. (TNDM)
USD 16.36
(-3.08%)
USD 16.36
(-3.08%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -222.61 Million USD | -135.33% |
| 2022 | -94.59 Million USD | -707.7% |
| 2021 | 15.56 Million USD | 145.27% |
| 2020 | -34.38 Million USD | -38.9% |
| 2019 | -24.75 Million USD | 79.81% |
| 2018 | -122.61 Million USD | -67.88% |
| 2017 | -73.03 Million USD | 12.48% |
| 2016 | -83.44 Million USD | -15.23% |
| 2015 | -72.41 Million USD | 8.94% |
| 2014 | -79.52 Million USD | -25.95% |
| 2013 | -63.13 Million USD | -91.24% |
| 2012 | -33.01 Million USD | -29.42% |
| 2011 | -25.5 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -30.81 Million USD | 27.86% |
| 2024 Q1 | -42.71 Million USD | -42.37% |
| 2023 Q3 | -32.96 Million USD | 7.87% |
| 2023 Q1 | -123.87 Million USD | -681.43% |
| 2023 FY | -222.61 Million USD | -135.33% |
| 2023 Q4 | -30 Million USD | 8.98% |
| 2023 Q2 | -35.77 Million USD | 71.12% |
| 2022 Q2 | -15.05 Million USD | -2.32% |
| 2022 Q4 | -15.85 Million USD | 67.63% |
| 2022 FY | -94.59 Million USD | -707.7% |
| 2022 Q1 | -14.71 Million USD | -236.15% |
| 2022 Q3 | -48.97 Million USD | -225.25% |
| 2021 Q4 | 10.8 Million USD | 86.54% |
| 2021 Q3 | 5.79 Million USD | 44.56% |
| 2021 Q1 | -5.04 Million USD | -129.67% |
| 2021 Q2 | 4 Million USD | 179.46% |
| 2021 FY | 15.56 Million USD | 145.27% |
| 2020 Q4 | 17 Million USD | 280.7% |
| 2020 FY | -34.38 Million USD | -38.9% |
| 2020 Q3 | -9.4 Million USD | 65.29% |
| 2020 Q2 | -27.1 Million USD | -82.33% |
| 2020 Q1 | -14.86 Million USD | -660.6% |
| 2019 Q4 | 2.65 Million USD | 191.42% |
| 2019 FY | -24.75 Million USD | 79.81% |
| 2019 Q1 | -22.99 Million USD | -723.77% |
| 2019 Q2 | -1.51 Million USD | 93.42% |
| 2019 Q3 | -2.9 Million USD | -91.87% |
| 2018 Q3 | -34.24 Million USD | 42.31% |
| 2018 Q2 | -59.35 Million USD | -81.56% |
| 2018 Q1 | -32.69 Million USD | -186.65% |
| 2018 FY | -122.61 Million USD | -67.88% |
| 2018 Q4 | 3.68 Million USD | 110.76% |
| 2017 Q2 | -21.8 Million USD | 8.37% |
| 2017 Q1 | -23.79 Million USD | -60.52% |
| 2017 FY | -73.03 Million USD | 12.48% |
| 2017 Q4 | -11.4 Million USD | 28.87% |
| 2017 Q3 | -16.03 Million USD | 26.44% |
| 2016 Q1 | -20.48 Million USD | -69.4% |
| 2016 FY | -83.44 Million USD | -15.23% |
| 2016 Q2 | -18.32 Million USD | 10.54% |
| 2016 Q4 | -14.82 Million USD | 50.29% |
| 2016 Q3 | -29.81 Million USD | -62.7% |
| 2015 Q2 | -19.53 Million USD | 7.9% |
| 2015 FY | -72.41 Million USD | 8.94% |
| 2015 Q3 | -19.58 Million USD | -0.27% |
| 2015 Q1 | -21.2 Million USD | -14.86% |
| 2015 Q4 | -12.09 Million USD | 38.26% |
| 2014 Q2 | -19.19 Million USD | 12.59% |
| 2014 FY | -79.52 Million USD | -25.95% |
| 2014 Q4 | -18.46 Million USD | 7.21% |
| 2014 Q3 | -19.89 Million USD | -3.66% |
| 2014 Q1 | -21.96 Million USD | 6.99% |
| 2013 Q3 | -13.06 Million USD | 14.64% |
| 2013 Q2 | -15.3 Million USD | -37.06% |
| 2013 Q1 | -11.16 Million USD | -30.51% |
| 2013 FY | -63.13 Million USD | -91.24% |
| 2013 Q4 | -23.61 Million USD | -80.79% |
| 2012 Q4 | -8.55 Million USD | -13.85% |
| 2012 Q3 | -7.51 Million USD | 0.0% |
| 2012 FY | -33.01 Million USD | -29.42% |
| 2011 FY | -25.5 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | -61.61 Million USD | -261.276% |
| IceCure Medical Ltd | -14.65 Million USD | -1419.322% |
| NeuroOne Medical Technologies Corporation | -11.85 Million USD | -1777.07% |
| Acutus Medical, Inc. | -81.66 Million USD | -172.597% |
| DIH Holding US, Inc. Warrants | 640.19 Thousand USD | 34872.32% |
| Bioventus Inc. | -156.23 Million USD | -42.489% |
| BrainsWay Ltd. | -4.19 Million USD | -5204.051% |
| Cerus Corporation | -37.48 Million USD | -493.804% |
| Venus Concept Inc. | -37.25 Million USD | -497.613% |
| Envoy Medical, Inc. | -29.9 Million USD | -644.319% |
| CVRx, Inc. | -41.19 Million USD | -440.331% |
| electroCore, Inc. | -18.83 Million USD | -1081.963% |
| Helius Medical Technologies, Inc. | -8.85 Million USD | -2415.379% |
| Inogen, Inc. | -102.44 Million USD | -117.29% |
| OrthoPediatrics Corp. | -20.97 Million USD | -961.366% |
| Lucid Diagnostics Inc. | -52.66 Million USD | -322.684% |
| Spectral AI, Inc. | -20.85 Million USD | -967.474% |
| Monogram Orthopaedics, Inc. | -13.74 Million USD | -1519.552% |
| MaxCyte, Inc. | -37.92 Million USD | -487.008% |
| Nano-X Imaging Ltd. | -60.77 Million USD | -266.281% |
| Nexalin Technology, Inc. | -4.64 Million USD | -4688.663% |
| Orthofix Medical Inc. | -151.39 Million USD | -47.04% |
| PAVmed Inc | -64.17 Million USD | -246.881% |
| Rapid Micro Biosystems, Inc. | -52.46 Million USD | -324.288% |
| RxSight, Inc. | -48.6 Million USD | -357.972% |
| Sight Sciences, Inc. | -55.54 Million USD | -300.762% |
| SI-BONE, Inc. | -43.33 Million USD | -413.686% |
| TELA Bio, Inc. | -46.66 Million USD | -377.051% |
| Treace Medical Concepts, Inc. | -49.52 Million USD | -349.474% |
| Vivos Therapeutics, Inc. | -13.58 Million USD | -1538.894% |
| TriSalus Life Sciences, Inc. | -59.03 Million USD | -277.064% |
| LivaNova PLC | 17.54 Million USD | 1368.728% |
| PetVivo Holdings, Inc. | -10.95 Million USD | -1931.995% |
| Talis Biomedical Corporation | -62 Million USD | -259.009% |
| 908 Devices Inc. | -36.39 Million USD | -511.585% |
| Alphatec Holdings, Inc. | -186.63 Million USD | -19.274% |
| Nemaura Medical Inc. | -14.14 Million USD | -1473.919% |
| NeuroPace, Inc. | -32.95 Million USD | -575.479% |
| LENSAR, Inc. | -14.38 Million USD | -1447.737% |
| Apyx Medical Corporation | -18.71 Million USD | -1089.606% |
| Cutera, Inc. | -162.83 Million USD | -36.711% |
| STRATA Skin Sciences, Inc. | -10.83 Million USD | -1955.503% |
| BioSig Technologies, Inc. | -29.04 Million USD | -666.54% |
| Anika Therapeutics, Inc. | -82.66 Million USD | -169.286% |
| ClearPoint Neuro, Inc. | -22.08 Million USD | -907.791% |
| Integra LifeSciences Holdings Corporation | 67.74 Million USD | 428.621% |
| Axonics, Inc. | -6.08 Million USD | -3556.554% |
| Outset Medical, Inc. | -172.79 Million USD | -28.828% |
| IRIDEX Corporation | -9.57 Million USD | -2226.134% |
| PROCEPT BioRobotics Corporation | -105.89 Million USD | -110.215% |
| IRadimed Corporation | 17.19 Million USD | 1394.794% |
| Tivic Health Systems, Inc. | -8.24 Million USD | -2600.279% |
| INVO Bioscience, Inc. | -8.03 Million USD | -2670.65% |
| Telesis Bio, Inc. | -47.72 Million USD | -366.455% |
| Viemed Healthcare, Inc. | 10.24 Million USD | 2273.299% |
| Varex Imaging Corporation | -47.7 Million USD | -366.69% |
| Quipt Home Medical Corp. | -2.78 Million USD | -7896.085% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | -1872.453% |
| Pulmonx Corporation | -60.84 Million USD | -265.878% |
| Dynatronics Corporation | -2.69 Million USD | -8151.823% |
| Modular Medical, Inc. | -17.47 Million USD | -1174.247% |
| ReShape Lifesciences Inc. | -11.38 Million USD | -1854.957% |
| Semler Scientific, Inc. | 20.58 Million USD | 1181.528% |
| InMode Ltd. | 197.91 Million USD | 212.476% |
| Bruker Corporation | 427.2 Million USD | 152.109% |
| Cytosorbents Corporation | -28.5 Million USD | -680.889% |
| DexCom, Inc. | 541.5 Million USD | 141.11% |
| Align Technology, Inc. | 445.05 Million USD | 150.019% |
| Viveve Medical, Inc. | -22.02 Million USD | -910.628% |
| ZimVie Inc. | -393.28 Million USD | 43.397% |
| Movano Inc. | -29.28 Million USD | -660.206% |
| Cytek Biosciences, Inc. | -12.14 Million USD | -1732.491% |
| Nexalin Technology, Inc. | -4.64 Million USD | -4688.663% |
| DIH Holdings US, Inc. Class A Common Stock | 640.19 Thousand USD | 34872.32% |
| Profound Medical Corp. | -28.56 Million USD | -679.205% |
| Insulet Corporation | 206.3 Million USD | 207.906% |
| enVVeno Medical Corporation | -23.51 Million USD | -846.636% |
| Surmodics, Inc. | -11.54 Million USD | -1828.704% |
| iCAD, Inc. | -4.84 Million USD | -4492.758% |
| Nuwellis, Inc. | -20.2 Million USD | -1001.544% |
| Biotricity, Inc. | -14.09 Million USD | -1479.442% |
| iRhythm Technologies, Inc. | -123.4 Million USD | -80.389% |
| Aethlon Medical, Inc. | -12.2 Million USD | -1723.459% |
| InspireMD, Inc. | -19.91 Million USD | -1017.75% |
| PAVmed Inc. | -64.17 Million USD | -246.881% |
| BIOLASE, Inc. | -20.63 Million USD | -978.96% |
| Beyond Air, Inc. | -60.24 Million USD | -269.528% |
| FONAR Corporation | 10.56 Million USD | 2206.583% |
| AxoGen, Inc. | -21.71 Million USD | -925.101% |
| Vivani Medical, Inc. | -25.65 Million USD | -767.811% |
| Tactile Systems Technology, Inc. | 28.51 Million USD | 880.68% |
| Inari Medical, Inc. | -1.63 Million USD | -13507.029% |
| UFP Technologies, Inc. | 44.92 Million USD | 595.528% |
| QT Imaging Holdings, Inc. | -5.13 Million USD | -4237.424% |
| Heart Test Laboratories, Inc. | -6.6 Million USD | -3270.235% |
| Tenon Medical, Inc. | -15.58 Million USD | -1328.734% |
| Autonomix Medical, Inc. Common Stock | -15.42 Million USD | -1343.09% |
| Co-Diagnostics, Inc. | -35.33 Million USD | -530.039% |
| AdaptHealth Corp. | -678.89 Million USD | 67.21% |
| Sintx Technologies, Inc. | -8.25 Million USD | -2595.375% |
| NanoVibronix, Inc. | -3.71 Million USD | -5898.68% |
| Quanterix Corporation | -32.33 Million USD | -588.473% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | -1872.453% |
| Sensus Healthcare, Inc. | 485 Thousand USD | 45999.175% |
| Pacific Biosciences of California, Inc. | -306.73 Million USD | 27.426% |
| TransMedics Group, Inc. | -25.02 Million USD | -789.448% |
| ReWalk Robotics Ltd. | -22.13 Million USD | -905.788% |
| NeuroMetrix, Inc. | -6.52 Million USD | -3309.318% |
| Hyperfine, Inc. | -44.23 Million USD | -403.212% |
| Establishment Labs Holdings Inc. | -78.5 Million USD | -183.574% |
| Biomerica, Inc. | -5.97 Million USD | -3623.837% |
| Bone Biologics Corporation | -8.94 Million USD | -2387.626% |
| AVITA Medical, Inc. | -39.16 Million USD | -468.346% |
| Bluejay Diagnostics, Inc. | -9.95 Million USD | -2136.423% |
| Silk Road Medical, Inc | -55.74 Million USD | -299.352% |